Description
Putting an End to Transplantation? Translating the Promise of Stem Cell Therapy into Practice
Brenda Ogle, PhD
(147) Impella RP Post Approval Study: First Multi-Center, Prospective Post Market Approval Results for the Impella RP in Patients with Right Ventriculoar Failure
Mark Anderson, MD
Interactive Discussant
Martin Strueber, MD
Tweets, Texts, and Posts: Does Social Media Improve or Complicate Communication in Medicine?
Dorry Segev, MD, PhD
Share and Share Alike: Optimizing Organ Allocation in an Era of Increasing Need
Sommer Gentry, PhD
(148) Early Graft Injury Measured by Donor-Derived Cell-Free DNA Predicts Early Mortality in Lung Transplant Recipients
Sean Agbor-Enoh, MD, PhD
Interactive Discussant
Erik Verschuuren, MD, PhD
Metabolomics: New Tools to Understand Rejection
Brendan Keating, PhD
Speaker(s):
- Brenda
Ogle,
PhD,
University of Minnesota
- Mark
Anderson,
MD,
Einstein Healthcare Network
- Martin
Strueber,
MD,
Beth Israel Medical Center, Newark, NJ, United States
- Dorry
Segev,
MD, PhD,
Johns Hopkins School of Medicine
- Sommer
Gentry,
PhD,
United States Naval Academy
- Sean
Agbor-Enoh,
MD,
Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD, United States
- Erik
Verschuuren,
MD, PhD,
University Medical Center, Groningen, Netherlands
- Brendan
Keating,
PhD,
Hospital of the University of Pennsylvania